Director's Acquisition of Shares

Craneware plc

04 March 2026

 

Craneware plc

("Craneware" or the "Company")

Director's Acquisition of Shares

Notification of Major Holdings and Exercise of Share Options

4 March 2026 - The Board of Craneware plc (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 2 March 2026, Keith Neilson, CEO of the Company, received 28,628 ordinary shares of 1p each in the Company ("Ordinary Shares") following the exercise of options over 28,628 Ordinary Shares, at an exercise price of 750 pence per Ordinary Share.

Mr. Neilson has chosen to retain the full quantity of shares from the exercise of share options rather than utilising the Company's net settlement facility to settle the exercise cost, income tax and national insurance contributions. These represent a total cost to Mr. Neilson of over £326,000 to retain the full award. 

As a result, following the exercise of these share options, Mr. Neilson's shareholding in the Company has increased to 3,214,471 Ordinary Shares in the capital of the Company, representing 9.05% of the Company's issued share capital (excluding 31,700 Ordinary Shares held in treasury).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Keith Neilson

2.   Reason for the notification

a) Position / status                                            CEO

b) Initial notification / Amendment                       Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument                                                         Ordinary Shares of 1p each in the capital of Craneware plc

b) Identification code                                         ISIN GB00B2425G68

c) Nature of the transaction                                Exercise of options over Ordinary Shares

d) Price(s) and volume(s)                                   Volume(s) 28,628, Price(s) £7.50

e) Aggregated information:                               

                                    i. Aggregated volume                28,628

                                    ii. Price                                     £7.50

f) Date of the transaction                                  2026-03-02

g) Place of the transaction                                 Outside a trading venue

For further information, please contact:

Craneware plc	[phone]
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications	[phone]
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal	[e-mail]
Peel Hunt (NOMAD and Joint Broker)	[phone]
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker)	[phone]
Patrick Robb, Virginia Bull, Arnav Kapoor
Berenberg (Joint Broker)	[phone]
Mark Whitmore, Richard Andrews, Patrick Dolaghan

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

 

END